FNCH logo

Finch Therapeutics (FNCH)

Profile

Full Name

Finch Therapeutics Group, Inc.

Ticker Symbol

FNCH

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 19, 2021

Indexes

Not included

Website

http://www.finchtherapeutics.com

Employees

1

Key Details

Price

$12.40(-0.80%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$107.00K(-87.57% YoY)

Annual EPS

-$46.59(+35.40% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$12.40
FNCH price is $12.40

30-Day Relative Volume

2.44
FNCH 30-day relative volume is 2.44

Price Performance

Price Most recent change

-0.8%
FNCH price was down -0.8% on Apr 11, 2025

Price YTD change

+9.73%
FNCH price is up +9.73% since January 1st

Price 1-year change

+427.66%
FNCH price is up +427.66% year-on-year

Price 3-year change

-90.32%
FNCH price is down -90.32% over the past 3 years

Price Range

Price All-time high

$675.00
FNCH price is currently -98.16% below its historical high of $675.00

Price 3-year low

$0.80
FNCH price is currently +1450.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$19.91M
FNCH market capitalization is $19.91 million

Market cap 3-year change

-90.19%
FNCH market capitalization is down -90.19% over the past 3 years

Market cap All-time high

$1.01B
FNCH market capitalization is currently -98.02% below its historical high of $1.01 billion

Market cap sector rank

27.61%
FNCH market capitalization is higher than 27.61% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
FNCH {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

+1.29%
FNCH shares outstanding is up +1.29% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.18
FNCH beta is 0.18

200-day SMA

$10.65
FNCH price is currently +16.47% above its 200-day simple moving average

50-day SMA

$14.12
FNCH price is currently -12.17% below its 50-day simple moving average

RSI

26.52
FNCH 14-day relative strength index is 26.52

Volume

2.44
FNCH 30-day relative volume is 2.44

ATR

$0.35
FNCH average true range is $0.35

10-day Historical Volatility

29.49%
FNCH 10-day historical volatility is 29.49%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$107.00K
FNCH annual revenue is $107.00 thousand

Revenue Analysts estimate

-
FNCH annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-87.57%
FNCH annual revenue is down -87.57% year-on-year

Revenue Sector rank

5.26%
FNCH annual revenue is higher than 5.26% of companies in Healthcare sector

EPS

EPS

-$46.59
FNCH annual earnings per share is -$46.59

EPS Analysts estimate

-$20.59
FNCH annual earnings per share is currently +126.27% higher than the consensus analysts' forecast

EPS 1-year change

+35.4%
FNCH annual earnings per share is up +35.4% year-on-year

EPS Sector rank

4.29%
FNCH annual earnings per share is higher than 4.29% of companies in Healthcare sector

Profit

Gross profit

-
FNCH annual gross profit value is unknown

Gross margin

-
FNCH annual gross profit margin value is unknown

Operating profit

-$34.00M
FNCH annual operating income is -$34.00 million

Operating margin

-31.78K%
FNCH annual operating profit margin is -31.78 thousand%

Net income

-$74.75M
FNCH annual net profit is -$74.75 million

Net margin

-69.86K%
FNCH annual net profit margin is -69.86 thousand%

Expenses

Total expenses

$34.11M
FNCH annual total expenses is $34.11 million

Operating expenses

$34.11M
FNCH annual total operating expenses is $34.11 million

Cost of goods sold

-
FNCH annual cost of goods sold value is unknown

Selling, general & administrative expenses

$26.91M
FNCH annual SGA is $26.91 million

Depreciation and amortization

$1.52M
FNCH annual depreciation & amortization is $1.52 million

Interest expense

-
FNCH annual interest expense value is unknown

Income tax

-$3.46M
FNCH annual income tax is -$3.46 million

EBIT & EBITDA

EBIT

-$34.00M
FNCH annual earnings before interest & taxes is -$34.00 million

EBITDA

-$32.48M
FNCH annual EBITDA is -$32.48 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$55.37M
FNCH annual total assets is $55.37 million

Non current assets

$29.53M
FNCH annual long term assets is $29.53 million

Current assets

$25.85M
FNCH annual total current assets is $25.85 million

Cash and cash equivalents

$25.12M
FNCH annual cash & cash equivalents is $25.12 million

Accounts receivable

$0.00
FNCH annual accounts receivable is $0.00

Inventory

-
FNCH annual inventory value is unknown

Liabilities

Total liabilities

$32.49M
FNCH annual total liabilities is $32.49 million

Long term liabilities

$28.40M
FNCH annual total long term liabilities is $28.40 million

Current liabilities

$4.08M
FNCH annual total current liabilities is $4.08 million

Accounts payable

$141.00K
FNCH annual accounts payable is $141.00 thousand

Debt

Total debt

$30.13M
FNCH annual total debt is $30.13 million

Total debt 1-year change

-42.44%
FNCH annual total debt is down -42.44% year-on-year

Long term debt

$28.40M
FNCH annual long term debt is $28.40 million

Short term debt

$1.72M
FNCH annual short term debt is $1.72 million

Equity & Capital

Shareholders equity

$22.89M
FNCH annual stockholders equity is $22.89 million

Book value

$22.89M
FNCH annual book value is $22.89 million

Retained earnings

-$350.39M
FNCH annual retained earnings is -$350.39 million

Working capital

$21.76M
FNCH annual working capital is $21.76 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$31.50M
FNCH annual cash flow from operations is -$31.50 million

Cash from operations 1-year change

+57.91%
FNCH annual cash flow from operations is up +57.91% year-on-year

Cash from investing

$1.33M
FNCH annual cash flow from investing activities is $1.33 million

Cash from investing 1-year change

+160.82%
FNCH annual cash flow from investing activities is up +160.82% year-on-year

Cash from financing

-$16.16M
FNCH annual cash flow from financing activities is -$16.16 million

Cash from financing 1-year change

-208.62%
FNCH annual cash flow from financing activities is down -208.62% year-on-year

CAPEX

CAPEX

-
FNCH annual capital expenditures value is unknown

CAPEX 1-year change

-
FNCH annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$31.50M
FNCH annual free cash flow is -$31.50 million

Free cash flow 1-year change

+59.1%
FNCH annual free cash flow is up +59.1% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
FNCH annual gross profit margin value is unknown

Operating margin

-31.78K%
FNCH annual operating profit margin is -31.78 thousand%

Net margin

-69.86K%
FNCH annual net profit margin is -69.86 thousand%

ROA & ROE

ROA

-68.48%
FNCH annual return on assets is -68.48%

ROE

-126.06%
FNCH annual return on equity is -126.06%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
FNCH price to earnings ratio value is unknown

PE ratio Sector rank

-
FNCH price to earnings ratio is unknown

PB Ratio

PB ratio

1.40
FNCH price to book ratio is 1.40

PB ratio Sector rank

53.29%
FNCH price to book ratio is higher than 53.29% of companies in Healthcare sector

PS Ratio

PS ratio

-
FNCH price to sales ratio value is unknown

PS ratio Sector rank

-
FNCH price to sales ratio is unknown

Enterprise value

Enterprise value

$32.87M
FNCH enterprise value is $32.87 million

Enterprise value Sector rank

37.02%
FNCH enterprise value is higher than 37.02% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.68
FNCH EV/EBITDA is -1.68

EV/EBITDA Sector rank

34.55%
FNCH EV/EBITDA is higher than 34.55% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

6.33
FNCH annual current ratio is 6.33

Quick ratio

-
FNCH annual quick ratio value is unknown

Leverage

Debt to equity

0.00
FNCH annual debt to equity ratio is 0.00

Interest coverage ratio

-
FNCH annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
FNCH piotroski f-score value is unknown

Altman Z-Score

-10.04
FNCH altman z-score is -10.04

Analyst ratings

Recent major analysts updates

May 12, 23 HC Wainwright & Co.
Buy
Apr 4, 23 HC Wainwright & Co.
Buy
Aug 9, 22 HC Wainwright & Co.
Buy
Apr 4, 22 Jefferies
Buy
Apr 13, 21 Jefferies
Buy
Apr 13, 21 Evercore ISI Group
Outperform
Apr 13, 21 B of A Securities
Buy

Institutional Ownership

Similar stocks

OVID logo
Ovid Therapeutics (OVID)
BFRG logo
Bullfrog AI Holdings (BFRG)
IPA logo
ImmunoPrecise Antibodies (IPA)
PULM logo
Pulmatrix (PULM)
CMMB logo
Chemomab Therapeutics (CMMB)
NEPH logo
Nephros (NEPH)
RVP logo
Retractable Technologies (RVP)
COEP logo
Coeptis Therapeutics (COEP)
CalciMedica (CALC)
  • What is the ticker symbol for Finch Therapeutics?
  • Does Finch Therapeutics pay dividends?
  • What sector is Finch Therapeutics in?
  • What industry is Finch Therapeutics in?
  • What country is Finch Therapeutics based in?
  • When did Finch Therapeutics go public?
  • Is Finch Therapeutics in the S&P 500?
  • Is Finch Therapeutics in the NASDAQ 100?
  • Is Finch Therapeutics in the Dow Jones?
  • When was Finch Therapeutics's last earnings report?
  • When does Finch Therapeutics report earnings?
  • Should I buy Finch Therapeutics stock now?

What is the ticker symbol for Finch Therapeutics?

The ticker symbol for Finch Therapeutics is NASDAQ:FNCH

Does Finch Therapeutics pay dividends?

No, Finch Therapeutics does not pay dividends

What sector is Finch Therapeutics in?

Finch Therapeutics is in the Healthcare sector

What industry is Finch Therapeutics in?

Finch Therapeutics is in the Biotechnology industry

What country is Finch Therapeutics based in?

Finch Therapeutics is headquartered in United States

When did Finch Therapeutics go public?

Finch Therapeutics's initial public offering (IPO) was on March 19, 2021

Is Finch Therapeutics in the S&P 500?

No, Finch Therapeutics is not included in the S&P 500 index

Is Finch Therapeutics in the NASDAQ 100?

No, Finch Therapeutics is not included in the NASDAQ 100 index

Is Finch Therapeutics in the Dow Jones?

No, Finch Therapeutics is not included in the Dow Jones index

When was Finch Therapeutics's last earnings report?

Finch Therapeutics's most recent earnings report was on Aug 13, 2024

When does Finch Therapeutics report earnings?

The next expected earnings date for Finch Therapeutics is May 9, 2025

Should I buy Finch Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page